Westfield Capital Management
PCRX icon

Westfield Capital Management’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,960
Closed -$1.16M 251
2022
Q4
$1.16M Sell
29,960
-490,737
-94% -$18.9M 0.01% 204
2022
Q3
$27.7M Sell
520,697
-4,839
-0.9% -$257K 0.22% 154
2022
Q2
$30.6M Buy
525,536
+107,034
+26% +$6.24M 0.24% 140
2022
Q1
$31.9M Sell
418,502
-674,980
-62% -$51.5M 0.2% 144
2021
Q4
$65.8M Sell
1,093,482
-32,837
-3% -$1.98M 0.39% 90
2021
Q3
$63.1M Buy
1,126,319
+95,674
+9% +$5.36M 0.38% 93
2021
Q2
$62.5M Buy
1,030,645
+503,548
+96% +$30.6M 0.37% 100
2021
Q1
$36.9M Sell
527,097
-399,891
-43% -$28M 0.23% 133
2020
Q4
$55.5M Buy
926,988
+14,213
+2% +$851K 0.33% 107
2020
Q3
$54.9M Sell
912,775
-448,467
-33% -$27M 0.36% 96
2020
Q2
$71.4M Buy
1,361,242
+361,072
+36% +$18.9M 0.49% 67
2020
Q1
$33.5M Buy
1,000,170
+258,781
+35% +$8.68M 0.3% 105
2019
Q4
$33.6M Buy
741,389
+226,460
+44% +$10.3M 0.24% 131
2019
Q3
$19.6M Buy
+514,929
New +$19.6M 0.16% 159
2018
Q2
Sell
-834,282
Closed -$26M 267
2018
Q1
$26M Sell
834,282
-411,641
-33% -$12.8M 0.2% 158
2017
Q4
$56.9M Sell
1,245,923
-39,927
-3% -$1.82M 0.43% 89
2017
Q3
$48.3M Buy
1,285,850
+64,510
+5% +$2.42M 0.37% 100
2017
Q2
$58.3M Sell
1,221,340
-387,507
-24% -$18.5M 0.5% 73
2017
Q1
$73.4M Buy
1,608,847
+5,166
+0.3% +$236K 0.63% 44
2016
Q4
$51.8M Buy
1,603,681
+365,273
+29% +$11.8M 0.45% 84
2016
Q3
$42.4M Sell
1,238,408
-95,460
-7% -$3.27M 0.34% 99
2016
Q2
$45M Buy
1,333,868
+640,814
+92% +$21.6M 0.37% 92
2016
Q1
$36.7M Buy
693,054
+23,494
+4% +$1.24M 0.28% 114
2015
Q4
$51.4M Sell
669,560
-719,604
-52% -$55.3M 0.35% 98
2015
Q3
$57.1M Sell
1,389,164
-104,888
-7% -$4.31M 0.4% 85
2015
Q2
$106M Buy
1,494,052
+766,062
+105% +$54.2M 0.64% 49
2015
Q1
$64.7M Buy
+727,990
New +$64.7M 0.37% 93